$ICCT
iCoreConnect Inc. Stock $icct

$icct Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000147793224007459 Filed on November 19, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$2.788M
YoY Change		39.06%
Cost Of Revenue		$827.0K
YoY Change		59.69%
Gross Profit		$1.961M
YoY Change		31.88%
Gross Profit Margin		70.34%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$4.161M
YoY Change		6.43%
Operating Profit		-$2.200M
YoY Change		-9.19%
Interest Expense		$223.1K
YoY Change		-53.38%
% of Operating Profit
Other Income/Expense, Net		-$3.790M
YoY Change		198.77%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		-$5.991M
YoY Change		53.2%
Net Earnings / Revenue		-214.88%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	24.32M shares	10.40M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$212.3K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$798.3K
Other Receivables
Total Short-Term Assets		$1.452M
YoY Change		-28.08%
LONG-TERM ASSETS
Property, Plant & Equipment		$179.1K
YoY Change		-10.63%
Goodwill		$1.485M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$12.77M
YoY Change		-11.24%
TOTAL ASSETS
Total Short-Term Assets		$1.452M
Total Long-Term Assets		$12.77M
Total Assets		$14.22M
YoY Change		-13.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due		$6.953M
YoY Change		88.16%
Total Short-Term Liabilities		$13.12M
YoY Change		45.84%
LONG-TERM LIABILITIES
Long-Term Debt		$3.138M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$4.119M
YoY Change		310.94%
TOTAL LIABILITIES
Total Short-Term Liabilities		$13.12M
Total Long-Term Liabilities		$4.119M
Total Liabilities		$17.24M
YoY Change		72.41%
SHAREHOLDERS EQUITY
Retained Earnings		-$138.2M
YoY Change		28.66%
Common Stock		$1.184K
YoY Change		41.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$3.021M
YoY Change
Total Liabilities & Shareholders Equity		$14.22M
YoY Change		-13.31%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$5.991M
YoY Change		53.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001906133
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	3755209	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4480845	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10068477	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11836277	shares
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-105676	usd
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	0	usd
	icct	Weighted Average Exercise Price Of Warrants Granted WeightedAverageExercisePriceOfWarrantsGranted	0.56
	icct	One Weighted Average Remaining Life Of Warrants In Years Beginning OneWeightedAverageRemainingLifeOfWarrantsInYearsBeginning	P9Y8M12D
	icct	One Weighted Average Remaining Life Of Warrants In Years Ending OneWeightedAverageRemainingLifeOfWarrantsInYearsEnding	P8Y10M24D
	icct	Two Preferred Stock Warrants Outstanding Beginning TwoPreferredStockWarrantsOutstandingBeginning	10122313	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41309
	dei	Entity Registrant Name EntityRegistrantName	iCoreConnect Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2462502
	dei	Entity Address Address Line1 EntityAddressAddressLine1	529 E. Crown Point Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 250
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ocoee
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34761
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	810-7706
	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	ICCT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24323510	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212346	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1219358	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	798329	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	563905	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	441200	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1725062	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	1451875	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3508325	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	179140	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	202421	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	934160	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1122412	usd
CY2024Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1536484	usd
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	903412	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	6079918	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	0	usd
CY2024Q3	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	2178837	usd
CY2023Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	2980412	usd
CY2024Q3	icct	Forward Purchase Agreement Amount ForwardPurchaseAgreementAmount	375279	usd
CY2023Q4	icct	Forward Purchase Agreement Amount ForwardPurchaseAgreementAmount	5484556	usd
CY2024Q3	us-gaap	Goodwill Goodwill	1484966	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1484966	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	12768784	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	12178179	usd
CY2024Q3	us-gaap	Assets Assets	14220659	usd
CY2023Q4	us-gaap	Assets Assets	15686504	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5094793	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3243338	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	345496	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	241945	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	6953285	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4720454	usd
CY2024Q3	icct	Related Party Notes Payable Current RelatedPartyNotesPayableCurrent	561337	usd
CY2023Q4	icct	Related Party Notes Payable Current RelatedPartyNotesPayableCurrent	550975	usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	167816	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	119598	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13122727	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8876310	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3138093	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1420137	usd
CY2024Q3	icct	Long Term Related Party Debt Net Of Current Maturities LongTermRelatedPartyDebtNetOfCurrentMaturities	323735	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	656739	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	945889	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4118567	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2366026	usd
CY2024Q3	us-gaap	Liabilities Liabilities	17241294	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11242336	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4480845	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	3755209	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	448	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	376	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11836277	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10068477	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1184	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1007	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	135191201	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119481543	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138213468	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115038758	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-3020635	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4444168	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14220659	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15686504	usd
CY2024Q3	us-gaap	Revenues Revenues	2787999	usd
CY2023Q3	us-gaap	Revenues Revenues	2004853	usd
	us-gaap	Revenues Revenues	8599262	usd
	us-gaap	Revenues Revenues	5701372	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	826990	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	517875	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1946704	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1493357	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1961009	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1486978	usd
	us-gaap	Gross Profit GrossProfit	6652558	usd
	us-gaap	Gross Profit GrossProfit	4208015	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3354831	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3589655	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17061929	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9189829	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	806509	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	320427	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2320952	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	900936	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	4161340	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	3910082	usd
	us-gaap	Operating Expenses OperatingExpenses	19382881	usd
	us-gaap	Operating Expenses OperatingExpenses	10090765	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2200331	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2423104	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12730323	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5882750	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	223060	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	478437	usd
	us-gaap	Interest Expense InterestExpense	951173	usd
	us-gaap	Interest Expense InterestExpense	1007120	usd
CY2024Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	632800	usd
CY2023Q3	us-gaap	Financing Interest Expense FinancingInterestExpense	370852	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	2378784	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	792930	usd
CY2024Q3	icct	Change In Fair Value Of Forward Purchase Agreement ChangeInFairValueOfForwardPurchaseAgreement	-2946604	usd
CY2023Q3	icct	Change In Fair Value Of Forward Purchase Agreement ChangeInFairValueOfForwardPurchaseAgreement	-419407	usd
	icct	Change In Fair Value Of Forward Purchase Agreement ChangeInFairValueOfForwardPurchaseAgreement	-5109277	usd
	icct	Change In Fair Value Of Forward Purchase Agreement ChangeInFairValueOfForwardPurchaseAgreement	-419407	usd
CY2024Q3	icct	Other Expense OtherExpense	-12000	usd
CY2023Q3	icct	Other Expense OtherExpense	0	usd
	icct	Other Expense OtherExpense	439622	usd
	icct	Other Expense OtherExpense	-13778	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3790464	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1268696	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8878856	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2205679	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5990795	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-3691800	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21609179	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8088429	usd
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	669532	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	218516	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1565531	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	218516	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6660327	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3910316	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23174710	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8306945	usd
CY2024Q3	icct	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.61
CY2023Q3	icct	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.54
	icct	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-2.22
	icct	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-1.23
CY2024Q3	icct	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	10899110	shares
CY2023Q3	icct	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	7260195	shares
	icct	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	10425627	shares
	icct	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	6744143	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4444168	usd
CY2024Q1	icct	Origination Fee In Convertible Debt Agreement Amount OriginationFeeInConvertibleDebtAgreementAmount	182004	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	840000	usd
CY2024Q1	icct	Stock Issued For Purchase Of Featherpay Amount StockIssuedForPurchaseOfFeatherpayAmount	4800000	usd
CY2024Q1	icct	Stock Issued For The Purchase Of Teamworx Amount StockIssuedForThePurchaseOfTeamworxAmount	575000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	507679	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-5170970	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6177880	usd
CY2024Q2	icct	Origination Fee In Convertible Debt Agreement Amount OriginationFeeInConvertibleDebtAgreementAmount	298324	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5277856	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-11343413	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	410649	usd
CY2024Q3	icct	Origination Fee In Convertible Debt Agreement Amount OriginationFeeInConvertibleDebtAgreementAmount	439040	usd
CY2024Q3	icct	Stock Issued For Conversion Of Debt Amount StockIssuedForConversionOfDebtAmount	138250	usd
CY2024Q3	icct	Conversion Of Preferred Stock To Common Stock Amount ConversionOfPreferredStockToCommonStockAmount	0	usd
CY2024Q3	icct	Stock Issued For In Kind Dividend Amount StockIssuedForInKindDividendAmount	1760809	usd
CY2024Q3	icct	Stock Issued For Purchase Of Assets Of Healthcare Circle Of Excellence Amount StockIssuedForPurchaseOfAssetsOfHealthcareCircleOfExcellenceAmount	30000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	156030	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	704914	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-6660327	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-3020635	usd
	us-gaap	Net Income Loss NetIncomeLoss	-21609179	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8088429	usd
	us-gaap	Depreciation Depreciation	23281	usd
	us-gaap	Depreciation Depreciation	13753	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2297671	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	887183	usd
	icct	Finance Fee FinanceFee	2378783	usd
	icct	Finance Fee FinanceFee	792930	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	155249	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	130439	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6490487	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1434900	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	842699	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	720357	usd
	icct	Change In Fair Value Of Forward Purchase Agreements ChangeInFairValueOfForwardPurchaseAgreements	-5109277	usd
	icct	Change In Fair Value Of Forward Purchase Agreements ChangeInFairValueOfForwardPurchaseAgreements	-419407	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-13778	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	334455	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	313288	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1283862	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	483073	usd
	icct	Increase Decrease In Right Of Use Asset Net Of Lease Liability IncreaseDecreaseInRightOfUseAssetNetOfLeaseLiability	-2653	usd
	icct	Increase Decrease In Right Of Use Asset Net Of Lease Liability IncreaseDecreaseInRightOfUseAssetNetOfLeaseLiability	-28223	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2046733	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2611741	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	53998	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	97684	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1258941	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1761951	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	370000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	500000	usd
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	usd
	icct	Cash Portion Of Consideration Paid To Acquire Assets Preferred Dental CashPortionOfConsiderationPaidToAcquireAssetsPreferredDental	0	usd
	icct	Cash Portion Of Consideration Paid To Acquire Assets Preferred Dental CashPortionOfConsiderationPaidToAcquireAssetsPreferredDental	-1559145	usd
	icct	Purchase Of Forward Purchase Agreement PurchaseOfForwardPurchaseAgreement	0	usd
	icct	Purchase Of Forward Purchase Agreement PurchaseOfForwardPurchaseAgreement	-7796672	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	28000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	154231	usd
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	1031003	usd
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	507596	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1901003	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9989644	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3616451	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	3733011	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1463519	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	6486732	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	5747497	usd
	icct	Proceeds From Issuance Of Series A Preferred Stock ProceedsFromIssuanceOfSeriesAPreferredStock	0	usd
	icct	Proceeds From Issuance Of Series A Preferred Stock ProceedsFromIssuanceOfSeriesAPreferredStock	18312298	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	540000	usd
	icct	Effect Of Merger Net Of Transaction Costs EffectOfMergerNetOfTransactionCosts	0	usd
	icct	Effect Of Merger Net Of Transaction Costs EffectOfMergerNetOfTransactionCosts	-9833243	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2152932	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12012831	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1007012	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	261236	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1219358	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	196153	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212346	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	457389	usd
	us-gaap	Interest Paid Net InterestPaidNet	315054	usd
	us-gaap	Interest Paid Net InterestPaidNet	348941	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	62	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
	icct	Common Stock Issued For Acquisitions CommonStockIssuedForAcquisitions	3	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. NATURE OF OPERATIONS </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iCoreConnect Inc. (formerly known as FG Merger Corp) (collectively with its subsidiary, the “Company”), a Delaware Corporation, is a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise platform of applications and services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prior to August 25, 2023, the Company was a special purpose acquisition company formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. On August 25, 2023 (the “Closing Date”), the Company consummated the business combination contemplated by the Merger Agreement and Plan of Reorganization by and among FG Merger Corp, a special purpose acquisition company incorporated in Delaware (“FGMC”), FG Merger Sub, Inc., a Nevada corporation and wholly owned subsidiary of FGMC (“Merger Sub”), and iCoreConnect Inc., a Nevada corporation(“iCore”), dated as of January 5, 2023 (“Merger Agreement”). Pursuant to the terms of the Merger Agreement, a business combination between FGMC and iCore. was affected through the merger of Merger Sub with and into iCore, with iCore. surviving the merger as a wholly owned subsidiary of FGMC. On the Closing Date, FGMC was renamed “iCoreConnect Inc.” and the previous iCoreConect Inc. was renamed “iCore Midco, Inc.” (“Old iCore”).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Business Combinations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 1, 2024 the Company completed the acquisitions for substantial all the assets of (a) Ally Commerce, Inc. dba FeatherPay; (b) Verifi Dental, Limited; and (c) Teamworx LLC which are all accounted for as asset acquisitions. On September 1, 2023, the Company completed the acquisitions for substantially all of the assets of Preferred Dental Development, LLC which was accounted for as an asset acquisition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Going Concern and Liquidity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the nine months ended September 30, 2024, the Company generated an operating loss of $12,730,323. In addition, at September 30, 2024, the Company has an accumulated deficit, and net working capital deficit of $138,213,468 and $11,670,852 respectively. The Company’s activities were primarily financed through private placements of equity securities and issuance of debt. The Company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations soon. Such financing may not be available on terms satisfactory to the Company, if at all. In light of these matters, there is substantial doubt that the Company will be able to continue as a going concern for a period of 12 months from the issuance date of these financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Currently, management intends to develop an improved healthcare communications system and intends to develop alliances with strategic partners to generate revenues that will sustain the Company. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company’s customer base and realize increased revenues from signed contracts. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p>
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12730323	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-138213468	usd
CY2024Q3	icct	Working Capital Deficit WorkingCapitalDeficit	-11670852	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59000	usd
	icct	Recurring Revenues RecurringRevenues	8062616	usd
	icct	Recurring Revenues RecurringRevenues	5170844	usd
	icct	Non Recurring Revenues NonRecurringRevenues	536646	usd
	icct	Non Recurring Revenues NonRecurringRevenues	530528	usd
	us-gaap	Advertising Expense AdvertisingExpense	528602	usd
	us-gaap	Advertising Expense AdvertisingExpense	435672	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for derivative instruments in accordance with ASC 815 “Derivatives and Hedging”, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.</p>
CY2023Q3	icct	Capital Stock Authorized CapitalStockAuthorized	140000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	icct	Common Stock Par Value CommonStockParValue	0.0001
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	17002897	usd
CY2024Q3	us-gaap	Secured Debt Repurchase Agreements SecuredDebtRepurchaseAgreements	12569810	usd
CY2024Q3	icct	Due From Officers Or Stockholders Or Related Party Current DueFromOfficersOrStockholdersOrRelatedPartyCurrent	4433087	usd
CY2024Q3	us-gaap	Sale Leaseback Transaction Historical Cost SaleLeasebackTransactionHistoricalCost	4433087	usd
CY2024Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10541275	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-6551775	usd
CY2023Q4	icct	Finite Lived Intangible Asset Net Carrying Amount FiniteLivedIntangibleAssetNetCarryingAmount	3883824	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	17117500	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-7322261	usd
CY2024Q3	icct	Finite Lived Intangible Asset Net Carrying Amount FiniteLivedIntangibleAssetNetCarryingAmount	9795239	usd
	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	2297671	usd
	icct	Deemed Commitment Shares Issued DeemedCommitmentSharesIssued	100000	shares
	icct	Redemption Price Per Shares RedemptionPricePerShares	10.69
CY2024Q3	us-gaap	Notes Payable NotesPayable	12204951	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	6337429	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	312795	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2024Q3	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	1800778	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Fee Cost FinancingReceivableUnamortizedLoanFeeCost	196837	usd
CY2024Q3	icct	Total Notes Payable Net Of Financing Costs TotalNotesPayableNetOfFinancingCosts	10091378	usd
CY2023Q4	icct	Total Notes Payable Net Of Financing Costs TotalNotesPayableNetOfFinancingCosts	6140592	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	6953285	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4720455	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	3138093	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1420137	usd
CY2023Q3	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1200000	usd
CY2023Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.12	pure
CY2023Q3	us-gaap	Interest Expense InterestExpense	38609	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	281921	shares
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	359725	shares
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	462243	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	icct	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBeginning	776328	shares
	icct	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceBeginning	3.75
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5247474	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.60
	icct	Weighted Average Remaining Contractual Term In Years Granted WeightedAverageRemainingContractualTermInYearsGranted	P9M15D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	2846	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
	icct	Weighted Average Remaining Contractual Term In Years Forfeited WeightedAverageRemainingContractualTermInYearsForfeited	P7M
	icct	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberEnding	6020956	shares
	icct	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceEnding	2.75
	icct	Weighted Average Remaining Contractual Term In Years Ending WeightedAverageRemainingContractualTermInYearsEnding	P9M6D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4715741	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.16
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9M6D
	icct	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares Beginning SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesBeginning	395072	shares
	icct	Weighted Average Grant Date Fair Value Nonvested Beginning WeightedAverageGrantDateFairValueNonvestedBeginning	3.76
	icct	Weighted Average Remaining Years To Vest Nonvested Begining WeightedAverageRemainingYearsToVestNonvestedBegining	P8M
	icct	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Granted Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantedNumberOfShares	5247474	shares
	icct	Weighted Average Grant Date Fair Values Nonvested Granted WeightedAverageGrantDateFairValuesNonvestedGranted	2.60
	icct	Weighted Average Remaining Years To Vest Nonvested Granted WeightedAverageRemainingYearsToVestNonvestedGranted	P9M15D
	icct	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsVestedNumberOfShares	-4351471	shares
	icct	Weighted Average Grant Date Fair Value Nonvested Vested WeightedAverageGrantDateFairValueNonvestedVested	3.16
	icct	Weighted Average Remaining Years To Vest Nonvested Vested WeightedAverageRemainingYearsToVestNonvestedVested	P9M6D
	icct	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeitedd Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeiteddNumberOfShares	-2846	shares
	icct	Weighted Average Grant Date Fair Values Nonvested Forfeited Expired WeightedAverageGrantDateFairValuesNonvestedForfeitedExpired	0
	icct	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares Ending SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesEnding	1288229	shares
	icct	Weighted Average Grant Date Fair Values Nonvested Ending WeightedAverageGrantDateFairValuesNonvestedEnding	1.66
	icct	Weighted Average Remaining Years To Vest Nonvested Ending WeightedAverageRemainingYearsToVestNonvestedEnding	P9M6D
	us-gaap	Restricted Stock Expense RestrictedStockExpense	279889	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	289167	usd
	icct	Number Of Warrants Outstanding Beginning NumberOfWarrantsOutstandingBeginning	45129	shares
	icct	Weighted Average Exercise Price Of Warrants Beginning WeightedAverageExercisePriceOfWarrantsBeginning	2.09
	icct	Weighted Average Remaining Life Of Warrants In Years Beginning WeightedAverageRemainingLifeOfWarrantsInYearsBeginning	P4M24D
	icct	Aggregate Intrinsic Value Of Warrants Beginning AggregateIntrinsicValueOfWarrantsBeginning	0	usd
	icct	Number Of Warrants Granted NumberOfWarrantsGranted	2930838	shares
	icct	Weighted Average Remaining Life Of Warrants In Years Granted WeightedAverageRemainingLifeOfWarrantsInYearsGranted	P4M24D
	icct	Weighted Average Exercise Price Of Warrants Exercised WeightedAverageExercisePriceOfWarrantsExercised	0
	icct	Weighted Average Exercise Price Of Warrants Cancelled WeightedAverageExercisePriceOfWarrantsCancelled	0
	icct	Number Of Warrants Outstanding Ending NumberOfWarrantsOutstandingEnding	2975967	shares
	icct	Weighted Average Exercise Price Of Warrants Ending WeightedAverageExercisePriceOfWarrantsEnding	0.58
	icct	Weighted Average Remaining Life Of Warrants In Years Ending WeightedAverageRemainingLifeOfWarrantsInYearsEnding	P4M24D
	icct	Aggregate Intrinsic Value Of Warrants Ending AggregateIntrinsicValueOfWarrantsEnding	0	usd
	icct	One Number Of Warrants Outstanding Beginning OneNumberOfWarrantsOutstandingBeginning	425800	shares
	icct	One Weighted Average Exercise Price Of Warrants Beginning OneWeightedAverageExercisePriceOfWarrantsBeginning	2.00
	icct	One Weighted Average Exercise Price Of Warrants Granted OneWeightedAverageExercisePriceOfWarrantsGranted	0
	icct	One Weighted Average Exercise Price Of Warrants Exercised OneWeightedAverageExercisePriceOfWarrantsExercised	0
	icct	One Weighted Average Exercise Price Of Warrants Expired OneWeightedAverageExercisePriceOfWarrantsExpired	0
	icct	One Number Of Warrants Outstanding Ending OneNumberOfWarrantsOutstandingEnding	425800	shares
	icct	One Weighted Average Exercise Price Of Warrants Ending OneWeightedAverageExercisePriceOfWarrantsEnding	2.00
	icct	Two Number Of Warrants Outstanding Ending TwoNumberOfWarrantsOutstandingEnding	10122313	shares
	icct	Two Weightedaverageexercisepriceofwarrantsbeginning TwoWeightedaverageexercisepriceofwarrantsbeginning	11.50
	icct	One Weighted Average Remaining Life Of Warrant In Years Beginning OneWeightedAverageRemainingLifeOfWarrantInYearsBeginning	P9M21D
	icct	Two Weightedaverageexercisepriceofwarrantsgranted TwoWeightedaverageexercisepriceofwarrantsgranted	0
	icct	Two Weightedaverageexercisepriceofwarrantsexercised TwoWeightedaverageexercisepriceofwarrantsexercised	0
	icct	Two Weightedaverageexercisepriceofwarrantsexpired TwoWeightedaverageexercisepriceofwarrantsexpired	0
	icct	Two Weightedaverageexercisepriceofwarrantsending TwoWeightedaverageexercisepriceofwarrantsending	11.50
	icct	One Weighted Average Remaining Life Of Warrants In Years Ending Balance OneWeightedAverageRemainingLifeOfWarrantsInYearsEndingBalance	P8M27D
	icct	Three Preferred Stock Warrants Outstanding Beginning ThreePreferredStockWarrantsOutstandingBeginning	1000000	shares
	icct	Three Weightedaverageexercisepriceofwarrantsbeginning ThreeWeightedaverageexercisepriceofwarrantsbeginning	15.00
	icct	Three Weighted Average Remaining Life Of Warrants In Years Beginning ThreeWeightedAverageRemainingLifeOfWarrantsInYearsBeginning	P9M21D
	icct	Three Weightedaverageexercisepriceofwarrantsgranted ThreeWeightedaverageexercisepriceofwarrantsgranted	0
	icct	Three Weightedaverageexercisepriceofwarrantsexercised ThreeWeightedaverageexercisepriceofwarrantsexercised	0
	icct	Three Weightedaverageexercisepriceofwarrantsexpired ThreeWeightedaverageexercisepriceofwarrantsexpired	0
	icct	Three Number Of Warrants Outstanding Ending ThreeNumberOfWarrantsOutstandingEnding	1000000	shares
	icct	Three Weightedaverageexercisepriceofwarrantsending ThreeWeightedaverageexercisepriceofwarrantsending	15.00
	icct	Three Weighted Average Remaining Life Of Warrants In Years Ending ThreeWeightedAverageRemainingLifeOfWarrantsInYearsEnding	P8M27D
CY2024Q3	us-gaap	Other Commitment OtherCommitment	1234070	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Registration Payment Arrangement Maximum Potential Consideration RegistrationPaymentArrangementMaximumPotentialConsideration	5300000	usd
CY2024Q1	us-gaap	Registration Payment Arrangement Maximum Potential Consideration RegistrationPaymentArrangementMaximumPotentialConsideration	1210000	usd
CY2024Q1	us-gaap	Registration Payment Arrangement Maximum Potential Consideration RegistrationPaymentArrangementMaximumPotentialConsideration	700000	usd
CY2024Q1	us-gaap	Cash Cash	0	usd
CY2024Q1	us-gaap	Cash Cash	871	usd
CY2024Q1	us-gaap	Cash Cash	12752	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	959	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	54259	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2024Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	5299041	usd
CY2024Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	1154870	usd
CY2024Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	678548	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	8700	usd
CY2024Q1	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue	5300000	usd
CY2024Q1	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue	1210000	usd
CY2024Q1	us-gaap	Acquired Finite Lived Intangible Asset Residual Value AcquiredFiniteLivedIntangibleAssetResidualValue	700000	usd
	icct	Scheduleosubsequent Eventstabletextblock ScheduleosubsequentEventstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Consideration Paid:</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>October 1, </strong><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,019,006</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">2,019,006</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Fair values of identifiable assets disposed:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Assets acquired:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Prepaid expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11,125</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Customer relationships</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,013,865</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(47,765</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total assets disposed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">977,225</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2024Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	2019006	usd
CY2024Q4	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	2019006	usd
CY2024Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	11125	usd
CY2024Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	1013865	usd
CY2024Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue	47765	usd
CY2024Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	977225	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	118425	usd

Files In Submission

Name	View Source	Status
0001477932-24-007459-index-headers.html	Edgar Link	pending
0001477932-24-007459-index.html	Edgar Link	pending
0001477932-24-007459.txt	Edgar Link	pending
0001477932-24-007459-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icct-20240930.xsd	Edgar Link	pending
icct_10q.htm	Edgar Link	pending
icct_ex311.htm	Edgar Link	pending
icct_ex312.htm	Edgar Link	pending
icct_ex321.htm	Edgar Link	pending
icct_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
icct-20240930_def.xml	Edgar Link	unprocessable
icct-20240930_pre.xml	Edgar Link	unprocessable
icct-20240930_lab.xml	Edgar Link	unprocessable
icct_10q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
icct-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICCT
iCoreConnect Inc. Stock $icct

2024 Q4 Form 10-Q Financial Statement

#000147793224007459 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCT iCoreConnect Inc. Stock $icct

2024 Q4 Form 10-Q Financial Statement

#000147793224007459 Filed on November 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCT
iCoreConnect Inc. Stock $icct